Title |
Injection allergen immunotherapy for asthma
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2010
|
DOI | 10.1002/14651858.cd001186.pub2 |
Pubmed ID | |
Authors |
Michael J Abramson, Robert M Puy, John M Weiner |
Abstract |
Allergen specific immunotherapy has long been a controversial treatment for asthma. Although beneficial effects upon clinically relevant outcomes have been demonstrated in randomised controlled trials, there remains a risk of severe and sometimes fatal anaphylaxis. The recommendations of professional bodies have ranged from cautious acceptance to outright dismissal. With increasing interest in new allergen preparations and methods of delivery, we updated the systematic review of allergen specific immunotherapy for asthma. |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 22% |
Canada | 2 | 9% |
Australia | 2 | 9% |
United States | 2 | 9% |
Argentina | 1 | 4% |
France | 1 | 4% |
Spain | 1 | 4% |
Israel | 1 | 4% |
Chile | 1 | 4% |
Other | 0 | 0% |
Unknown | 7 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 61% |
Scientists | 5 | 22% |
Practitioners (doctors, other healthcare professionals) | 3 | 13% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 324 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 2 | <1% |
Germany | 2 | <1% |
Portugal | 1 | <1% |
United Kingdom | 1 | <1% |
Canada | 1 | <1% |
Unknown | 317 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 40 | 12% |
Other | 38 | 12% |
Student > Master | 33 | 10% |
Student > Bachelor | 26 | 8% |
Student > Ph. D. Student | 20 | 6% |
Other | 64 | 20% |
Unknown | 103 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 128 | 40% |
Agricultural and Biological Sciences | 17 | 5% |
Immunology and Microbiology | 14 | 4% |
Biochemistry, Genetics and Molecular Biology | 12 | 4% |
Nursing and Health Professions | 11 | 3% |
Other | 31 | 10% |
Unknown | 111 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2022.
All research outputs
#566,883
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,008
of 11,499 outputs
Outputs of similar age
#1,418
of 104,265 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 74 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,265 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.